Similar relationships were demonstrated by Palermo et al. (2024), indicating that elevated IL-6 levels are associated with poorer metabolic outcomes and higher cardiovascular risk in individuals with metabolic syndrome [32]. The gene discussed is IL6; the disease is metabolic syndrome.